Regenerx Biopharma (RGRX) Receives EPO Notice of Intent to Grant Patent Related to Thymosin Beta 4
Go back to Regenerx Biopharma (RGRX) Receives EPO Notice of Intent to Grant Patent Related to Thymosin Beta 4| Regenerx Biopharmaceuticals, Inc. (AMEX: RGRX) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $0.75 | |||
| Open | $0.00 | 52 Week Low | $0.25 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-0.07 | |||
| Volume | 1,000 | |||||
